Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective studyMaliazurina B. Saad, Jia Wu, Kang Qin et al.|The Lancet Digital Health|2023Cited by 108
Considerations in the reliability and fairness audits of predictive models for advance care planningJonathan Lu, Nigam H. Shah, Amelia Sattler et al.|Frontiers in Digital Health|2022Cited by 36
Abstract LB181: First disclosure of XRD-0394, a novel dual ATM/DNA-PK inhibitor, that potently radiosensitizes and potentiates PARP and topoisomerase inhibitorsTona M. Gilmer, Michael B. Kastan, Chun-Hsiang Lai et al.|Cancer Research|2024Cited by 4